Development and validation of a deep reinforcement learning algorithm for auto-delineation of organs at risk in cervical cancer radiotherapy.
Source check: Source checked. Not independent scientific confirmation.
Finding: Full PMC article reports SAM-plus-deep-reinforcement-learning auto-delineation of cervical-cancer organs at risk, compared with manual contours and commercial deep-learning software. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.
Technology: PPO reinforcement learning selects SAM prompt points for CT organ segmentation.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- PPO reinforcement learning selects SAM prompt points for CT organ segmentation.
- Test and result
- The represented result is improved OAR delineation for cervical radiotherapy CT.
- Limitation / still unknown
- 122 training and 28 test CT cases; DSC, HD95, ASSD and RAVD compare against manual ground truth and commercial DL.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC11861648/unicode
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.